• Abel K, Compton L, Rourke T. Simian-Human immunodeficiency virus SHIV89.6-induced pro-tection against intravaginal challenge with pathogenic SIVmac239 is independent of the route of immunization and is associated with a combination of cytotoxic T-lymphocyte and alpha interferon responses[J]. J Virol, 2003, 77(5): 3099-3118. doi: 10.1128/JVI.77.5.3099-3118.2003

  • Cong Z, Tu X M, Jiang H. Application of PCR techniques in detection of simian immunodeficiency virus (SIV) in monkey infection models[J]. Acta Lab Anim Sci Sin, 2005, 13(2): 84-87.

  • Estaquier J, Monceaux V, Cumont M C. Early changes in peripheral blood T cells during primary infection of rhesus macaques with a pathogenic SIV[J]. J Med Primatol, 2000, 29(3-4): 127-135.

  • Girard M, Mahoney J, Wei Q. Genital infection of female chimpanzees with human immun-odeficiency virus type 1[J]. AIDS Res Hum Retrovirused, 1998, 14(15): 1357-1367. doi: 10.1089/aid.1998.14.1357

  • Guo W Z, Lu Y Z, Wu X X. Experimental study on ATA prescription in treating monkey with chronic infection of simian immunodeficiency virus[J]. J Guangzhou Univ Tradit Chin Medi, 2005, 22(4): 296-298.

  • Kuwata T, Kodama M, Sato A. Contribution of monocytes to viral replication in macaques during acute infection with simian immunodeficiency virus[J]. AIDS Res Hum Retroviruses, 2007, 23(3): 372-380. doi: 10.1089/aid.2006.0208

  • Li M H, He Z Y, Zheng Y T. The scapegoat of human AIDS research: non-human primate models[J]. Chin J Nat, 2005, 27(4): 208-212.

  • Li M H, Zhang G H, Sun T. The value of nonhuman primate animal models in anti-HIV drug studies[J]. Chin J New Drug, 2007, 16(16): 1237-1242.

  • Ling B, Veazey R S, Penedo C. Longitudinal follow up of SIVmac phthogenesis in rhesus macaques of Chinese origin: emergence of B cell lymphoma[J]. J Med Primatol, 2002, 31(): 154-163. doi: 10.1034/j.1600-0684.2002.02001.x

  • Lu Y Z, Wu X X, Tu X M. The establishment of SIV-infected macaque models[J]. Acta Lab Anim Sci Sin, 1994, 2(2): 94-101.

  • McDermott A B, Mitchen J, Piaskowski S. Repeated low-dose mucosal simian immunodeficiency virus SIVmac239 challenge results in the same viral and immunological kinetics as high-dose challenge: a model for the evaluation of vaccine efficacy in nonhuman primates[J]. J Virol, 2004, 78(6): 3140-3144. doi: 10.1128/JVI.78.6.3140-3144.2004

  • Metzner K J, Moretto W J, Donahoe S M. Evaluation of CD8+ T-cell and antibody responses follo-wing transient increased viraemia in rhesus macaques infected with live, attenuated simian immunodeficiency virus[J]. J Gen Virol, 2005, 86(): 3375-3384. doi: 10.1099/vir.0.81206-0

  • Miller C J, Abel K. Immune mechanisms associated with protection from vaginal SIV challenge in rhesus monkeys infected with virulence-attenuated SHIV89.6[J]. J Med Primatol, 2005, 34(5-6): 271-281. doi: 10.1111/jmp.2005.34.issue-5-6

  • Muller M C, Barre-Sinoussi F. SIVagm: genetic and biological features associated with replication[J]. Front Biosci, 2003, 8(): 1170-1185. doi: 10.2741/1130

  • Yamamoto H, Kawada M, Tsukamoto T. Vaccine-based, long-term, stable control of simian/human immunodeficiency virus 89.6PD replication in rhesus macaques[J]. J Gen Virol, 2007, 88(): 652-659. doi: 10.1099/vir.0.82469-0